The hormone receptor status is typically determined through a biopsy of the cancer tissue. The sample is analyzed in a laboratory using tests such as Immunohistochemistry (IHC) to detect the presence of estrogen and progesterone receptors. The results are usually reported as a percentage indicating the proportion of cells that test positive for the receptors.
